asclzi9u | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/asclzi9u_hasAnnotation_C0242656> <https://research.tib.eu/covid-19/entity/asclzi9u_hasAnnotation_C1825598>
?:creator	<https://research.tib.eu/covid-19/entity/Ciurea%2C_Adrian%3B_Finckh%2C_Axel>
?:doi	<https://research.tib.eu/covid-19/entity/10.1136/annrheumdis-2020-219420>
?:doi	10.1136/annrheumdis-2020-219420
?:journal	Annals_of_the_rheumatic_diseases
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/33177100>
?:pmid	33177100
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/asclzi9u_HAS_C5203670_AFFECTS_C0242656>
?:source	Medline
?:title	Response to \'Correspondence on \'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort\' by Ruyssen-Witrand et al.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-11

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/asclzi9u>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/asclzi9u>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all